What does Femasys Inc. do?

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through…

What is Femasys Inc.'s P/E and P/B ratio?

Femasys Inc. has a P/E ratio of -0.5 and a P/B ratio of 3.24.

What is Femasys Inc.'s debt-to-equity ratio?

Femasys Inc. has a debt-to-equity ratio of 1.19.

How much does Femasys Inc. owe compared with what it owns?

Femasys Inc. owes $0.67 for every $1 it owns (balance sheet Jun 2026), which is moderate.

Does Femasys Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Femasys Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 15 Jan 2026). It has no yellow flags.

Where can I read the latest news about Femasys Inc.?

Recent headlines about Femasys Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Femasys Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Femasys Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Femasys Inc.

Q: What is Femasys Inc.'s Positivity rank?

Femasys Inc. is ranked #4,627 of 6,774 companies globally and #2,366 of 4,000 in United States on PositoAI, with a Positivity Score of 19,196.

NasdaqCM: FEMY · Healthcare

Positivity Index

#4,627 / 6,774

Global

#2,366 / 4,000

United States

Positivity Score

19,196

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 15 Jan 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Femasys Inc. — Overview & Financial Snapshot

Femasys Inc. (NasdaqCM: FEMY) is a Healthcare company, ranked #4,627 of 6,774 companies globally and #2,366 of 4,000 in United States on PositoAI, with a Positivity Score of 19,196. Its market capitalisation is ₹123.32 Cr ($13.07M), P/E ratio is -0.5 and P/B ratio is 3.24. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →